Skip to content
by IQAC KIITKIIT Deemed to be University — Internal Quality Assurance Cell

Publication2022

Synergy of nanocarriers with CRISPR-Cas9 in an emerging technology platform for biomedical appliances: Current insights and perspectives

The record

Type
Publication
Date
1 December 2022
Level
International — held abroad
Journal
Materials and Design
Volume
224
Published
1 December 2022
DOI
10.1016/j.matdes.2022.111415
Scopus ID
85143505914
ISSN
02641275
Authors
13
Open access
Yes
Citations
26
International co-authorship
Yes
Co-author countries
CZ, IN, SE

Classification

Every label below carries the reasoning it was assigned on, the confidence band it was assigned in, and what produced it. The rubric is published.

UN Sustainable Development Goals

  1. 3 Ensure healthy lives and promote well-being for all at all ages

    GoalPrimaryHigh confidenceJudged

    CRISPR-nanocarrier platform directly addresses cancer, neurological diseases, diabetes, autoimmune disorders, muscular dystrophy and cardiovascular disease therapeutic outcomes.

    High confidence
    The subject matter is a strong and direct inference from the record type, the funding or organising body, or the programme context, even where the title alone is thin. Example: an ICMR-funded project against SDG 3, on the strength of the agency.
    Judged
    Judged against the published classification rubric, under the rubric and prompt versions recorded with the run that produced it.
    Produced by
    claude-haiku-4-5-20251001, under kortex-publication-v1

  2. 9.5 Enhance scientific research, upgrade technological capabilities, and increase researchers and R&D spending

    TargetSecondaryHigh confidenceJudged

    CRISPR-Cas9 and nanocarrier technology integration represents cutting-edge biotechnology innovation in genetic engineering and drug delivery research.

    Produced by
    claude-haiku-4-5-20251001, under kortex-publication-v1

  3. 17.6 Enhance North-South, South-South and triangular cooperation on science, technology and innovation, and knowledge sharing

    TargetSecondaryHigh confidenceRule-derivedrule sdg17-structural-v1

    Structural signal: co-authorship outside India.

    Rule-derived
    Emitted by a deterministic rule from structural signals rather than judged from the record’s text. The rule carries a version, so rule-derived and judged labels stay separable.
    Produced by
    sdg17-structural-v1, under kortex-publication-v1

Viksit Bharat @2047

  1. vb-1.2 Health and well-being

    Sub-themePrimaryHigh confidenceJudged

    Genetic therapy platform addresses multiple major disease categories enhancing health and well-being through innovative therapeutic mechanisms.

    Produced by
    claude-haiku-4-5-20251001, under kortex-publication-v1

Each label above carries the instrument and the version that produced it. How each classification is reached.

Evidence

Kortex hosts no documents. Evidence is an outbound link to the authority that holds it.

No outbound evidence link is recorded for this activity. The record below states which source it came from and when it was last read.

Provenance

Which source system this record came from, how many source rows were resolved into it, and when each was last read.

Source rows resolved into this record
1

Each record carries the date Kortex last read it from its source system. That is a freshness date and not a verification: Kortex records what its sources say and when it read them, and it does not check those statements against any external authority. No claim on this site is described as verified, because none is.

Citing this record

This URL is stable. A record’s permalink is frozen when it is published and is not regenerated if its title is later corrected.

KIIT Deemed to be University. “Synergy of nanocarriers with CRISPR-Cas9 in an emerging technology platform for biomedical appliances: Current insights and perspectives”. Kortex.

Explore the full record